Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 17 Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 6 Prostatic Neoplasms 5 Melanoma 5 Lung Neoplasms 5 Solid Tumor 3 Pain, Postoperative 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Gastrointestinal Stromal Tumors 3 Colorectal Neoplasms 3 Anxiety Disorders 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Pain 2 Glioma 2 Colonic Neoplasms 2 Choledocholithiasis 2 Choledochal Cyst 2 Carcinoma 2 Advanced Solid Tumor 2 Advanced Malignancies 2 cMET-dysregulated Advanced Solid Tumors 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1

Interventions

Propofol 1 Midazolam 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sedation × Midazolam × Clear all

NCT03343873 2024-08-01

ACTION

Beijing Tiantan Hospital

Phase NA Recruiting

Sedation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡